{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:13:38Z","timestamp":1793315618471,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01750-1","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:21:52Z","timestamp":1744723312000},"page":"3731-3746","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["KPT-330, A New Candidate Drug for Targeting NOTCH1 Overexpression in T-cell Acute Lymphoblastic Leukemia, An In Vitro and Silico Study"],"prefix":"10.1007","volume":"83","author":[{"given":"Fariha","family":"Naz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba","family":"Wali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiqa","family":"Nudrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian Abdur Rehaman","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Qandeel","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-0667","authenticated-orcid":false,"given":"Saadiya","family":"Zia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"1750_CR1","doi-asserted-by":"crossref","unstructured":"Abdeldaim, A. M., Sahlol, A. T., Elhoseny, M., & Hassanien, A. E. (2018). Computer-aided acute lymphoblastic leukemia diagnosis system based on image analysis. In: Advances in soft computing and machine learning in image processing. 131\u2013147, Springer International Publishing.","DOI":"10.1007\/978-3-319-63754-9_7"},{"key":"1750_CR2","doi-asserted-by":"crossref","unstructured":"Mughal, T. (2018). Precision haematological cancer medicine. CRC Press, Boca Raton.","DOI":"10.1201\/9781315380513"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard, F., & Mohty, M. (2020). Acute lymphoblastic leukaemia. The Lancet, 395, 1146\u20131162.","journal-title":"The Lancet"},{"key":"1750_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.22.00142","volume":"7","author":"M Tufail","year":"2023","unstructured":"Tufail, M., & Wu, C. (2023). Cancer statistics in Pakistan from 1994\u20132021: Data from cancer registry. JCO Clinical Cancer Informatics, 7, e2200142.","journal-title":"JCO Clinical Cancer Informatics"},{"key":"1750_CR5","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger, T., & Abdul-Hay, M. J. B. C. J. (2017). Acute lymphoblastic leukemia: A comprehensive review and 2017 update. Blood Cancer Journal, 7, e577.","journal-title":"Blood Cancer Journal"},{"key":"1750_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/2643-3230.BCD-20-0093","volume":"2","author":"V Cordo\u2019","year":"2021","unstructured":"Cordo\u2019, V., van der Zwet, J. C., Cant\u00e9-Barrett, K., Pieters, R., & Meijerink, J. P. (2021). T-cell acute lymphoblastic leukemia: A roadmap to targeted therapies. Blood Cancer Discovery, 2, 19\u201331.","journal-title":"Blood Cancer Discovery"},{"key":"1750_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/JLB.5VMR0818-330RR","volume":"105","author":"M Olivas-Aguirre","year":"2019","unstructured":"Olivas-Aguirre, M., Pottosin, I., & Dobrovinskaya, O. (2019). Mitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia. Journal of Leukocyte Biology, 105, 935\u2013946.","journal-title":"Journal of Leukocyte Biology"},{"key":"1750_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-019-0705-x","volume":"12","author":"J Zhao","year":"2019","unstructured":"Zhao, J., Song, Y., & Liu, D. (2019). Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia. Journal of Hematology and Oncology, 12, 17.","journal-title":"Journal of Hematology and Oncology"},{"key":"1750_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00638-2","volume":"8","author":"A Lahera","year":"2024","unstructured":"Lahera, A., Vela-Mart\u00edn, L., Fern\u00e1ndez-Navarro, P., Llamas, P., L\u00f3pez-Lorenzo, J. L., Cornago, J., & Villa-Morales, M. (2024). PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK\/STAT pathway mutations in T-ALL\/LBL. NPJ Precision Oncology, 8, 152.","journal-title":"NPJ Precision Oncology"},{"key":"1750_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/cyto.b.21882","volume":"98","author":"P Bonaccorso","year":"2020","unstructured":"Bonaccorso, P., Bugarin, C., Buracchi, C., Fazio, G., Biondi, A., Lo Nigro, L., & Gaipa, G. (2020). Single\u2010cell profiling of pediatric T\u2010cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K\/Akt and JAK\u2013STAT signaling pathways. Cytometry Part B: Clinical Cytometry, 98, 491\u2013503.","journal-title":"Cytometry Part B: Clinical Cytometry"},{"key":"1750_CR11","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1038\/s41375-021-01291-5","volume":"35","author":"JC van der Zwet","year":"2021","unstructured":"van der Zwet, J. C., Buijs-Gladdines, J. G., Cordo\u2019, V., Debets, D. O., Smits, W. K., Chen, Z., & Meijerink, J. P. (2021). MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia, 35, 3394\u20133405.","journal-title":"Leukemia"},{"key":"1750_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10032","volume":"21","author":"N Erkasap","year":"2021","unstructured":"Erkasap, N., Ozyurt, R., Ozkurt, M., Erkasap, S., Yasar, F., Ihtiyar, E., & Colak, E. (2021). Role of Notch, IL\u20111 and leptin expression in colorectal cancer. Experimental and Therapeutic Medicine, 21, 1\u201311.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"1750_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/sci.2018.02.02","volume":"5","author":"V Venkatesh","year":"2018","unstructured":"Venkatesh, V., Nataraj, R., Thangaraj, G. S., Karthikeyan, M., Gnanasekaran, A., Kaginelli, S. B., & Basalingappa, K. M. (2018). Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investigation, 5, 5.","journal-title":"Stem Cell Investigation"},{"key":"1750_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","volume":"50","author":"D Sprinzak","year":"2021","unstructured":"Sprinzak, D., & Blacklow, S. C. (2021). Biophysics of Notch signaling. Annual Review of Biophysics, 50, 157\u2013189.","journal-title":"Annual Review of Biophysics"},{"key":"1750_CR15","doi-asserted-by":"publisher","first-page":"152149","DOI":"10.1016\/j.imbio.2021.152149","volume":"226","author":"EK Nashwa","year":"2021","unstructured":"Nashwa, E. K., Aziz, M. A. A., Hesham, M., Matbouly, S., Mostafa, S. A., Bakkar, A., & Abdelmaksoud, M. F. (2021). Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia. Immunobiology, 226, 152149.","journal-title":"Immunobiology"},{"key":"1750_CR16","first-page":"1124","volume":"129","author":"M Sanchez-Martin","year":"2017","unstructured":"Sanchez-Martin, M., & Ferrando, A. (2017). The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. The Journal of the American Society of Hematology, 129, 1124\u20131133.","journal-title":"The Journal of the American Society of Hematology"},{"key":"1750_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fonc.2020.00764","volume":"10","author":"Y Cho","year":"2020","unstructured":"Cho, Y., & Kim, Y. K. (2020). Cancer stem cells as a potential target to overcome multidrug resistance. Frontiers in Oncology, 10, 764.","journal-title":"Frontiers in Oncology"},{"key":"1750_CR18","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.clml.2019.09.084","volume":"19","author":"D White","year":"2019","unstructured":"White, D., LeBlanc, R., Venner, C., Bahlis, N. J., Lentzsch, S., Gasparetto, C. J., & Schiller, G. J. (2019). Safety and efficacy of the combination of selinexor, lenalidomide and dexamethasone (SRd) in patients with relapsed\/refractory multiple myeloma (RRMM). Clinical Lymphoma, Myeloma and Leukemia, 19, e55.","journal-title":"Clinical Lymphoma, Myeloma and Leukemia"},{"key":"1750_CR19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s40265-019-01188-9","volume":"79","author":"YY Syed","year":"2019","unstructured":"Syed, Y. Y. (2019). Selinexor: First global approval. Drugs, 79, 1485\u20131494.","journal-title":"Drugs"},{"key":"1750_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods, 25, 402\u2013408.","journal-title":"Methods"},{"key":"1750_CR21","unstructured":"Eli L., & Company and the National Center for Advancing Translational Sciences (2004) Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK144065\/."},{"key":"1750_CR22","doi-asserted-by":"publisher","first-page":"109513","DOI":"10.1016\/j.mehy.2019.109513","volume":"136","author":"S Zia","year":"2020","unstructured":"Zia, S., Batool, S., & Shahid, R. (2020). Could PCSK9 be a new therapeutic target of Eugenol? In vitro and in silico evaluation of hypothesis. Medical Hypotheses, 136, 109513.","journal-title":"Medical Hypotheses"},{"key":"1750_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/19491034.2022.2076965","volume":"13","author":"M Tingey","year":"2022","unstructured":"Tingey, M., Li, Y., Yu, W., Young, A., & Yang, W. (2022). Spelling out the roles of individual nucleoporins in nuclear export of mRNA. Nucleus, 13, 172\u2013195.","journal-title":"Nucleus"},{"key":"1750_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1755","volume":"14","author":"M Khan","year":"2023","unstructured":"Khan, M., Hou, S., Chen, M., & Lei, H. (2023). Mechanisms of RNA export and nuclear retention. Wiley Interdisciplinary Reviews RNA, 14, e1755.","journal-title":"Wiley Interdisciplinary Reviews RNA"},{"key":"1750_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-6433-8_13","volume":"1490","author":"M Biesiada","year":"2016","unstructured":"Biesiada, M., Purzycka, K. J., Szachniuk, M., Blazewicz, J., & Adamiak, R. W. (2016). Automated RNA 3D structure prediction with RNAComposer. RNA Structure Determination: Methods and Protocols, 1490, 199\u2013215.","journal-title":"RNA Structure Determination: Methods and Protocols"},{"key":"1750_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.str.2010.12.021","volume":"19","author":"Q Yang","year":"2011","unstructured":"Yang, Q., Coseno, M., Gilmartin, G. M., & Doubli\u00e9, S. (2011). Crystal structure of a human cleavage factor CFIm25\/CFIm68\/RNA complex provides an insight into poly (A) site recognition and RNA looping. Structure, 19, 368\u2013377.","journal-title":"Structure"},{"key":"1750_CR27","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan, Y., Zhang, D., Zhou, P., Li, B., & Huang, S. Y. (2017). HDOCK: A web server for protein\u2013protein and protein\u2013DNA\/RNA docking based on a hybrid strategy. Nucleic Acids Research, 45, W365\u2013W373.","journal-title":"Nucleic Acids Research"},{"key":"1750_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O., & Olson, A. J. (2010). AutoDock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455\u2013461.","journal-title":"Journal of Computational Chemistry"},{"key":"1750_CR29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera\u2014a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25, 1605\u20131612.","journal-title":"Journal of Computational Chemistry"},{"key":"1750_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/ci200454v","volume":"52","author":"A Volkamer","year":"2012","unstructured":"Volkamer, A., Kuhn, D., Grombacher, T., Rippmann, F., & Rarey, M. (2012). Combining global and local measures for structure-based druggability predictions. Journal of chemical information and modeling, 52, 360\u2013372.","journal-title":"Journal of chemical information and modeling"},{"key":"1750_CR31","unstructured":"DeLano, W. L., & Bromberg, S. (2004). PyMOL user\u2019s guide. DeLano Scientific LLC. 629. San Carlos, California, U.S.A."},{"key":"1750_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.18231\/j.ijpo.2024.059","volume":"11","author":"T Sharma","year":"2024","unstructured":"Sharma, T., Thiyam, U., Thangjam, S., Banashree, R., Singh, I. A., & Singh, K. A. (2024). The immunophenotypic and clinicohematological characteristics of T-ALL cases detected over a three-year period in a tertiary institution. Indian Journal of Pathology and Oncology, 11, 270\u2013276.","journal-title":"Indian Journal of Pathology and Oncology"},{"key":"1750_CR33","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1080\/10428194.2022.2032033","volume":"63","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y., Li, J., Xue, T. L., Hu, H. R., Lin, W., Liu, S. G., & Gao, C. (2022). Prognostic significance of NOTCH1\/FBXW7 mutations in pediatric T cell acute lymphoblastic leukemia: A study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol. Leukemia and Lymphoma, 63, 1624\u20131633.","journal-title":"Leukemia and Lymphoma"},{"key":"1750_CR34","doi-asserted-by":"publisher","first-page":"1218989","DOI":"10.3389\/fonc.2023.1218989","volume":"13","author":"EC Silva Barcelos","year":"2023","unstructured":"Silva Barcelos, E. C., Rompietti, C., Adamo, F. M., Dorillo, E., De Falco, F., Del Papa, B., & Sportoletti, P. (2023). NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential. Frontiers in Oncology, 13, 1218989.","journal-title":"Frontiers in Oncology"},{"key":"1750_CR35","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3324\/haematol.2019.217687","volume":"105","author":"V Agnusdei","year":"2019","unstructured":"Agnusdei, V., Minuzzo, S., Pinazza, M., Gasparini, A., Pezz\u00e8, L., Amaro, A. A., & Indraccolo, S. (2019). Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts. Haematologica, 105, 1317.","journal-title":"Haematologica"},{"key":"1750_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-024-10169-5","volume":"52","author":"V Sokolova","year":"2025","unstructured":"Sokolova, V., Gruber, R., Pammer, L. M., Kocher, F., Klieser, E., Amann, A., & Seeber, A. (2025). Prognostic and functional role of the nuclear export receptor 1 (XPO1) in gastrointestinal cancers: A potential novel target? Molecular Biology Reports, 52, 1\u201330.","journal-title":"Molecular Biology Reports"},{"key":"1750_CR37","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.3390\/ijms21176341","volume":"21","author":"M Sendino","year":"2020","unstructured":"Sendino, M., Omaetxebarria, M. J., Prieto, G., & Rodriguez, J. A. (2020). Using a simple cellular assay to map NES motifs in cancer-related proteins, gain insight into CRM1-mediated NES export, and search for NES-harboring micropeptides. International Journal of Molecular Sciences, 21, 6341.","journal-title":"International Journal of Molecular Sciences"},{"key":"1750_CR38","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1158\/1535-7163.MCT-15-0104","volume":"14","author":"S Kazim","year":"2015","unstructured":"Kazim, S., Malafa, M. P., Coppola, D., Husain, K., Zibadi, S., Kashyap, T., & Mahipal, A. (2015). Selective nuclear export inhibitor KPT-330 enhances the antitumor activity of gemcitabine in human pancreatic cancer. Molecular Cancer Therapeutics, 14, 1570\u20131581.","journal-title":"Molecular Cancer Therapeutics"},{"key":"1750_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s42003-024-06140-6","volume":"7","author":"K Mittal","year":"2024","unstructured":"Mittal, K., Cooper, G. W., Lee, B. P., Su, Y., Skinner, K. T., Shim, J., & Hong, A. L. (2024). Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. Communications Biology, 7, 426.","journal-title":"Communications Biology"},{"key":"1750_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113867","volume":"9","author":"HI Wettersten","year":"2014","unstructured":"Wettersten, H. I., Landesman, Y., Friedlander, S., Shacham, S., Kauffman, M., & Weiss, R. H. (2014). Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth. PLoS ONE, 9, e113867.","journal-title":"PLoS ONE"},{"key":"1750_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/bjc.2014.260","volume":"111","author":"H Sun","year":"2014","unstructured":"Sun, H., Hattori, N., Chien, W., Sun, Q., Sudo, M., Ding, L., & Koeffler, H. P. (2014). KPT-330 has antitumour activity against non-small cell lung cancer. British Journal of Cancer, 111, 281\u2013291.","journal-title":"British Journal of Cancer"},{"key":"1750_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bjh.12231","volume":"161","author":"J Etchin","year":"2013","unstructured":"Etchin, J., Sanda, T., Mansour, M. R., Kentsis, A., Montero, J., Le, B. T., & Thomas Look, A. (2013). KPT\u2010330 inhibitor of CRM 1 (XPO 1)\u2010mediated nuclear export has selective anti\u2010leukaemic activity in preclinical models of T\u2010cell acute lymphoblastic leukaemia and acute myeloid leukaemia. British Journal of Haematology, 161, 117\u2013127.","journal-title":"British Journal of Haematology"},{"key":"1750_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-018-0049-2","volume":"4","author":"D Nie","year":"2018","unstructured":"Nie, D., Huang, K., Yin, S., Li, Y., Xie, S., & Ma, L. (2018). KPT-330 inhibition of chromosome region maintenance 1 is cytotoxic and sensitizes chronic myeloid leukemia to Imatinib. Cell Death Discovery, 4, 48.","journal-title":"Cell Death Discovery"},{"key":"1750_CR44","first-page":"3819","volume":"130","author":"DA Luedtke","year":"2017","unstructured":"Luedtke, D. A., Su, Y., Edwards, H., Lin, H., Taub, J. W., & Ge, Y. (2017). Inhibition of XPO1 by KPT-330 (selinexor) enhances cell death induced by the Bcl-2 selective inhibitor ABT-199 (venetoclax) through downregulation of Mcl-1 in acute myeloid leukemia. Blood, 130, 3819.","journal-title":"Blood"},{"key":"1750_CR45","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3390\/ijms19082396","volume":"19","author":"S Mirabilii","year":"2018","unstructured":"Mirabilii, S., Ricciardi, M. R., Piedimonte, M., Gianfelici, V., Bianchi, M. P., & Tafuri, A. (2018). Biological aspects of mTOR in leukemia. International Journal of Molecular Sciences, 19, 2396.","journal-title":"International Journal of Molecular Sciences"},{"key":"1750_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/sci.2019.02.03","volume":"6","author":"AY Wang","year":"2019","unstructured":"Wang, A. Y., & Liu, H. (2019). The past, present, and future of CRM1\/XPO1 inhibitors. Stem Cell Investigation, 6, 6.","journal-title":"Stem Cell Investigation"},{"key":"1750_CR47","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/1060028019892643","volume":"54","author":"TJ Peterson","year":"2020","unstructured":"Peterson, T. J., Orozco, J., & Buege, M. (2020). Selinexor: A first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma. Annals of Pharmacotherapy, 54, 577\u2013582.","journal-title":"Annals of Pharmacotherapy"},{"key":"1750_CR48","first-page":"139","volume":"1","author":"M Sendino","year":"2018","unstructured":"Sendino, M., Omaetxebarria, M. J., & Rodr\u00edguez, J. A. (2018). Hitting a moving target: Inhibition of the nuclear export receptor XPO1\/CRM1 as a therapeutic approach in cancer. Cancer Drug Resistance, 1, 139\u2013163.","journal-title":"Cancer Drug Resistance"},{"key":"1750_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59994-5","volume":"14","author":"N Chakravarti","year":"2024","unstructured":"Chakravarti, N., Boles, A., Burzinski, R., Sindaco, P., Isabelle, C., McConnell, K., & Porcu, P. (2024). XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53\u2013p21 and p27 pathways. Scientific Reports, 14, 9305.","journal-title":"Scientific Reports"},{"key":"1750_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-020-00903-4","volume":"13","author":"NG Azizian","year":"2020","unstructured":"Azizian, N. G., & Li, Y. (2020). XPO1-dependent nuclear export as a target for cancer therapy. Journal of Hematology and Oncology, 13, 61.","journal-title":"Journal of Hematology and Oncology"},{"key":"1750_CR51","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/ph14111131","volume":"14","author":"M Gargantilla","year":"2021","unstructured":"Gargantilla, M., L\u00f3pez-Fern\u00e1ndez, J., Camarasa, M. J., Persoons, L., Daelemans, D., Priego, E. M., & P\u00e9rez-P\u00e9rez, M. J. (2021). Inhibition of XPO-1 mediated nuclear export through the michael-acceptor character of chalcones. Pharmaceuticals, 14, 1131.","journal-title":"Pharmaceuticals"},{"key":"1750_CR52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00203-023-03761-z","volume":"206","author":"T Sharma","year":"2024","unstructured":"Sharma, T., Mondal, T., Khan, S., Churqui, M. P., Nystr\u00f6m, K., Thombare, K., & Dong, J. J. (2024). Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19. Archives of Microbiology, 206, 69.","journal-title":"Archives of Microbiology"},{"key":"1750_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85036","volume":"12","author":"RS Herron","year":"2023","unstructured":"Herron, R. S., Kunisky, A. K., Madden, J. R., Anyaeche, V. I., Maung, M. Z., & Hwang, H. W. (2023). A twin UGUA motif directs the balance between gene isoforms through CFIm and the mTORC1 signaling pathway. eLife, 12, e85036.","journal-title":"eLife"},{"key":"1750_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050322","volume":"5","author":"AF Palazzo","year":"2007","unstructured":"Palazzo, A. F., Springer, M., Shibata, Y., Lee, C. S., Dias, A. P., & Rapoport, T. A. (2007). The signal sequence coding region promotes nuclear export of mRNA. PLoS Biology, 5, e322.","journal-title":"PLoS Biology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01750-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:33:17Z","timestamp":1757201597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01750-1","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"2 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}